Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Richardson P, Griffin I, Tucker C, Smith D, et al. Lancet 2020 Feb 4. pii: S0140-6736(20)30304.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Richardson P, Griffin I, Tucker C, Smith D, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet 2020 Feb 4. pii: S0140-6736(20)30304.
PMID: 32032529